Investigation of saliva IgG neutralizing antibodies after vaccination against SARS-CoV-2
Not Applicable
- Conditions
- COVID-19
- Registration Number
- JPRN-UMIN000047028
- Lead Sponsor
- Kanagawa Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects who have been infected with the SARS-CoV-2 infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine whether neutralizing IgG antibodies increase in blood, but also correlate and increase in saliva. Correlation coefficients of 7 or higher will be used as outcome measures.
- Secondary Outcome Measures
Name Time Method